Global Guidelines and Initiatives from the European Confederation of Medical Mycology to improve Patient Care and Research Worldwide New Leadership is about Working Together

Martin Hoenigl (1, 2) , Jean-Pierre Gangneux (3) , Esther Segal (4) , Alexandre Alanio (5, 6) , Arunaloke Chakrabarti (7) , Sharon C-A Chen (8) , Nelesh Govender (9) , Ferry Hagen (10) , Nikolaj Klimko , Jacques F Meis , Alessandro C Pasqualotto (11) , Danila Seidel (12) , Thomas J Walsh , Katrien Lagrou (13) , Cornelia Lass-Flörl , Oliver A Cornely (12)

1 UCLA - University of California [Los Angeles]
2 Medical University of Graz
3 Irset - Institut de recherche en santé, environnement et travail
4 TAU - Tel Aviv University
5 Mycologie moléculaire - Molecular Mycology
6 Hôpital Saint-Louis
7 Postgraduate Institute of Medical Education and Research
8 UNSW - University of New South Wales [Sydney]
9 WITS - University of the Witwatersrand [Johannesburg]
10 WI - Westerdijk Fungal Biodiversity Institute [Utrecht]
11 Santa Casa de Misericórdia de Porto Alegre
12 University of Cologne
13 KU Leuven - Catholic University of Leuven = Katholieke Universiteit Leuven

Invasive mycoses present a global challenge with expansion into new hosts, emergence of new pathogens, and development of multidrug resistance. In parallel, new antifungal agents and advanced laboratory diagnostic systems are being developed. In response to these evolving challenges, the European Confederation of Medical Mycology (ECMM) is committed to providing international expertise, guidance, and leadership with the key objectives of improving diagnosis, treatment, outcome, and survival of persons with invasive fungal diseases. Representing 25 affiliated National Medical Mycology Societies, the ECMM has developed several major ways to achieving these critical objectives: (a) tasking specific medical mycology working groups; (b) founding the ECMM Academy and Fellow program (FECMM); (c) expanding the goals of ECMM beyond the European region; (d) implementing the ECMM Excellence Centre Initiative in Europe; and (e) the ECMM Global Guidelines and Neglected Orphan Disease Guidance Initiatives focusing on mucormycosis, rare mould diseases, rare yeast diseases, and endemic mycoses. We believe that these important initiatives and other strategies of the ECMM will advance the field of medical mycology and improve the outcome of patients with invasive mycoses worldwide.

Mots clés: Aspergillosis; Aspergillus; Guideline; Epidemiology; Candida; Low-resource; Mucormycoses; recommendation

Domaines: Santé publique et épidémiologie; Maladies infectieuses

Martin Hoenigl, Jean-Pierre Gangneux, Esther Segal, Alexandre Alanio, Arunaloke Chakrabarti, et al.. Global Guidelines and Initiatives from the European Confederation of Medical Mycology to improve Patient Care and Research Worldwide New Leadership is about Working Together. Mycoses, 2018, 61 (11), pp.885-894. ⟨10.1111/myc.12836⟩. ⟨hal-01863269⟩